Fire Retardant Chemical Detox 6041 NDC 63083-6041

NDC codes

FDA NDC Directory

Product NDC (as listed)63083-6041Labeler and product segments. Claims need a package NDC.

Product NDC at billing width63083-6041Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
63083-6041-2	63083604102	59 mL in 1 BOTTLE, DROPPER (63083-6041-2)Marketed from Aug 15, 1985

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Fire Retardant Chemical Detox 6041Suffix: 6041
Generic name (nonproprietary): fire retardant chemical detox
Active ingredients: Boric acid — 12 [hp_X]/59mLBoron oxide — 12 [hp_X]/59mL
Dosage form: Liquid
Route: Oral
Labeler: Professional Complementary Health Formulas
Product type: Over-the-counter drug
Marketing category: Unapproved homeopathic
Marketing start: Aug 15, 1984
Listing expires: Dec 31, 2027
Identifiers: Product ID 63083-6041_ef804f7f-09ca-4ffe-a8c4-a0cae207b71fSPL ID ef804f7f-09ca-4ffe-a8c4-a0cae207b71fSPL set ID e85b0277-11a0-44f6-9945-155f8adec954UNII R57ZHV85D4, 483W67CPF4

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N463083604102 followed by a unit qualifier and the quantity

Package 63083-6041-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 8, 2026.

Indications (excerpt from the label)

INDICATIONS For the temporary relief of runny nose, cough, shortness of breath, irritated skin, occasional headache, nausea or vomiting, diarrhea, or weakness due to sensitivity to or exposure to fire retardant chemicals.*

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)